目錄:北京索萊寶科技有限公司>>抗體>>Polyclonal Antibody>> K106667PAnti-C13orf15 Polyclonal Antibody
| 供貨周期 | 現(xiàn)貨 | 規(guī)格 | 50ul/100ul |
|---|---|---|---|
| 貨號 | K106667P | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,環(huán)保,生物產(chǎn)業(yè),農(nóng)業(yè) |
| 主要用途 | WB IHC |
Anti-C13orf15 Polyclonal Antibody
| 英文名稱 | Anti-C13orf15 Polyclonal Antibody |
|---|---|
| 宿主 | Rabbit |
| 別名 | RGCC;RGC32;KIAA0564;MGC87338;response gene to complement 32 |
| 應(yīng)用 | WB IHC |
| 稀釋比例 | WB 1:500-2000. IHC 1:20-50. |
| 交叉反應(yīng) | Human |
| 蛋白分子量 | 15kDa |
| Gene ID | 28984 |
| 保存 | Store at -20°C. Avoid freeze / thaw cycles. |
| 儲存液 | Buffer: PBS with 0.03% Proclin300, 50% glycerol, pH7.3. |
| 純化方法 | Affinity purification |
| 亞型 | IgG |
| 免疫原 | A synthetic peptide of human C13orf15 |
| 性狀 | 液體 |
| Public Immunogen Range | A synthetic peptide of human C13orf15 |
| Subcellular Locations | Cytoplasm Nucleus |
| Swiss Prot | Q9H4X1 |
| 克隆類型 | Polyclonal Antibody |
| 背景資料 | Modulates the activity of cell cycle-specific kinases. Enhances CDK1 activity. May contribute to the regulation of the cell cycle. May inhibit growth of glioma cells by promoting arrest of mitotic progression at the G2/M transition. Fibrogenic factor contributing to the pathogenesis of renal fibrosis through fibroblast activation. |
(空格分隔,最多3個,單個標(biāo)簽最多10個字符)
15
化工儀器網(wǎng)